<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: switzerland</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Swiss groups fear study undercuts assisted suicide</title>
   	 <description>(AP)—Swiss groups that aid people seeking to end their lives say they fear a national research program could lead to stricter rules for assisted suicide.</description>
     <link>http://medicalxpress.com/news/2013-04-swiss-groups-undercuts-suicide.html</link>
	 <category>Other</category>
	 <pubDate>Thu, 25 Apr 2013 15:20:01 EST</pubDate>
	 <guid isPermaLink="false">news286121362</guid>
	 
</item>
<item>
     <title>Swiss healer gets 13 years jail for infecting 16 with HIV</title>
   	 <description>A Swiss court on Friday sentenced a self-proclaimed healer to almost 13 years in prison for injecting 16 people with HIV-tainted blood and infecting them with the virus.</description>
     <link>http://medicalxpress.com/news/2013-03-swiss-acupuncturist-convicted-hiv.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Fri, 22 Mar 2013 11:50:06 EST</pubDate>
	 <guid isPermaLink="false">news283167665</guid>
	 
</item>
<item>
     <title>Italy lifts ban on Novartis flu vaccines</title>
   	 <description>Italian health authorities on Friday lifted a ban on the sale of flu vaccines made by Swiss pharmaceutical giant Novartis, saying that tests had shown they were not a health risk.</description>
     <link>http://medicalxpress.com/news/2012-11-italy-novartis-flu-vaccines.html</link>
	 <category>Medications</category>
	 <pubDate>Fri, 09 Nov 2012 08:26:14 EST</pubDate>
	 <guid isPermaLink="false">news271671963</guid>
	 
</item>
<item>
     <title>Novartis insists its flu vaccines are safe</title>
   	 <description>Swiss pharmaceutical giant Novartis insisted early Thursday that its flu vaccines were safe despite a sales ban by Italy, Switzerland and Austria.</description>
     <link>http://medicalxpress.com/news/2012-10-novartis-insists-flu-vaccines-safe.html</link>
	 <category>Medications</category>
	 <pubDate>Thu, 25 Oct 2012 04:09:23 EST</pubDate>
	 <guid isPermaLink="false">news270356943</guid>
	 
</item>
<item>
     <title>Pulmonary hypertension combination therapy may lead to greater disease burden</title>
   	 <description>Patients with pulmonary arterial hypertension (PAH) receiving combination therapy with intravenous (IV) PGI2 may suffer from greater disease burden compared with those receiving monotherapy or combination therapy, excluding IV PGI2.</description>
     <link>http://medicalxpress.com/news/2012-10-pulmonary-hypertension-combination-therapy-greater.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 22 Oct 2012 03:26:50 EST</pubDate>
	 <guid isPermaLink="false">news270095200</guid>
	 
</item>
<item>
     <title>Novartis chief sees sales dip until mid-2013</title>
   	 <description> Swiss pharmaceutical giant Novartis said Sunday the expiry of a US patent for its leading hypertension drug Diovan caused a drop in turnover that could last into the first half of 2013.</description>
     <link>http://medicalxpress.com/news/2012-10-novartis-chief-sales-dip-mid-.html</link>
	 <category>Medications</category>
	 <pubDate>Sun, 07 Oct 2012 05:58:03 EST</pubDate>
	 <guid isPermaLink="false">news268808275</guid>
	 
</item>
<item>
     <title>African research identifies strong candidate for possible single-dose malaria cure</title>
   	 <description>A recently discovered compound from the aminopyridine class not only has the potential to become part of a single-dose cure for all strains of malaria, but might also be able to block transmission of the parasite from person to person, according to a research collaboration involving the Medicines for Malaria Venture (MMV), based in Switzerland, and the Drug Discovery and Development Centre (H3-D) at the University of Cape Town, South Africa. On the basis of initial results it was selected by MMV for further development – making it the first compound researched on African soil to enter preclinical development in partnership with MMV.</description>
     <link>http://medicalxpress.com/news/2012-08-african-strong-candidate-single-dose-malaria.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 28 Aug 2012 11:27:11 EST</pubDate>
	 <guid isPermaLink="false">news265371990</guid>
	 
</item>
<item>
     <title>Zurich children's hospital lifts ban on circumcision</title>
   	 <description> A Swiss hospital announced Friday that it has lifted a moratorium on religiously-motivated circumcisions imposed in July in the wake of a court ruling in neighbouring Germany.</description>
     <link>http://medicalxpress.com/news/2012-08-zurich-children-hospital-circumcision.html</link>
	 <category>Other</category>
	 <pubDate>Fri, 10 Aug 2012 07:45:34 EST</pubDate>
	 <guid isPermaLink="false">news263803528</guid>
	 
</item>
<item>
     <title>Controversial Down's syndrome testing gets Swiss go-ahead</title>
   	 <description> Switzerland has given the green light for a new prenatal test for Down's syndrome amid controversy over whether this will lead to more abortions, a Swiss newspaper reported Sunday.</description>
     <link>http://medicalxpress.com/news/2012-07-controversial-syndrome-swiss-go-ahead.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Sun, 29 Jul 2012 11:25:19 EST</pubDate>
	 <guid isPermaLink="false">news262779913</guid>
	 
</item>
<item>
     <title>Researchers descover melanoma-promoting gene</title>
   	 <description>Black skin cancer, also known as melanoma, is particularly aggressive and becoming increasingly common in Switzerland. Despite intensive research, however, there is still no treatment. Researchers from the University of Zurich have now discovered a gene that plays a central role in black skin cancer. Suppressing this gene in mice inhibits the development of melanoma and its proliferation &amp;#150; a discovery that could pave the way for new forms of therapy.&amp;#160;&amp;#160;&amp;#160;</description>
     <link>http://medicalxpress.com/news/2012-07-descover-melanoma-promoting-gene.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 10 Jul 2012 08:44:28 EST</pubDate>
	 <guid isPermaLink="false">news261128653</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/trsdt4e5t.jpg" width="90" height="90" />
</item>
<item>
     <title>Olympic effort adapting to life after elite sport, new study finds</title>
   	 <description>While some Olympic athletes excel in their transition into life beyond elite sport others are experiencing problems like disorientation, depression and self-doubt, a new study from The University of Queensland has found. </description>
     <link>http://medicalxpress.com/news/2012-07-olympic-effort-life-elite-sport.html</link>
	 <category>Health</category>
	 <pubDate>Mon, 09 Jul 2012 08:16:06 EST</pubDate>
	 <guid isPermaLink="false">news261040559</guid>
	 
</item>
<item>
     <title>EU approves skin cancer fighting drug: Roche</title>
   	 <description> Swiss drug giant Roche said on Monday it had been given European Union approval for its treatment to fight a highly aggressive form of skin cancer.</description>
     <link>http://medicalxpress.com/news/2012-02-eu-skin-cancer-drug-roche.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 20 Feb 2012 07:13:03 EST</pubDate>
	 <guid isPermaLink="false">news248944365</guid>
	 
</item>
<item>
     <title>Novartis announces 2,000 job losses, profits up</title>
   	 <description> Swiss pharmaceutical giant Novartis announced 2,000 job losses Tuesday, mostly in Switzerland and the United States, while reporting net profits of $3.53 billion (2.5 billion euros) for the third quarter.</description>
     <link>http://medicalxpress.com/news/2011-10-novartis-job-losses-profits.html</link>
	 <category>Other</category>
	 <pubDate>Tue, 25 Oct 2011 04:47:01 EST</pubDate>
	 <guid isPermaLink="false">news238736805</guid>
	 
</item>
<item>
     <title>The size and burden of mental disorders in Europe</title>
   	 <description>A major landmark study released today by the European College of Neuropsychopharmacology (ECNP) sheds new light on the state of Europe's mental and neurological health. The study finds reveal that mental disorders have become Europe's largest health challenge in the 21st century. The study also highlights that the majority of mental disorders remain untreated. Taken together with the large and increasing number of 'disorders of the brain', the true size and burden is even significantly higher.</description>
     <link>http://medicalxpress.com/news/2011-09-size-burden-mental-disorders-europe.html</link>
	 <category>Psychology &amp; Psychiatry</category>
	 <pubDate>Mon, 05 Sep 2011 08:35:49 EST</pubDate>
	 <guid isPermaLink="false">news234430527</guid>
	 
</item>
<item>
     <title>When you can recite a poem but not remember who asked you to learn it a few days earlier</title>
   	 <description>Memory is not a single process but is made up of several sub-processes relying on different areas of the brain. Episodic memory, the ability to remember specific events such as what you did yesterday, is known to be vulnerable to brain damage involving the hippocampus. The question is, what happens when damage to the hippocampus occurs very early in life? In a case study published in the September 2011 issue of Elsevier's Cortex, clinical neuropsychologists have reported that a child can develop normally despite severe damage to the hippocampus resulting from lack of oxygen in the first days of life. This supports the theory that the different aspects of memory rely on distinct areas of the brain.</description>
     <link>http://medicalxpress.com/news/2011-08-recite-poem-days-earlier.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Thu, 11 Aug 2011 10:14:43 EST</pubDate>
	 <guid isPermaLink="false">news232276468</guid>
	 
</item>


</channel>
</rss>
